To test the potential of DNA methylation in regulating lgr5 expression, we first examined the expression of lgr5 in seven colorectal cancer cell lines and its alteration in response to 5-aza-2’-deoxycytidine (DAC), the classical methylation inhibitor. The gene discussed is LGR5; the disease is colorectal cancer.